Quantinuum (QNT) Falls Below Its $60 IPO Price as Revenue Shrinks 73%
Quantinuum was sold as the quantum sector’s first real institutional listing: a full-stack platform, a Honeywell pedigree, a book that came in roughly twenty times oversubscribed, an offer walked up from a $45–$50 range to $53–$55 and finally priced at $60. Two sessions in, the stock is below its offer price. The debut did not break because quantum sentiment collapsed. It broke because the price embedded a decade of execution that the financials do not support. A $60 offer was a sentiment trade, and sentiment trades reprice fastest.
The Setup
The company sold 28 million Class A shares at $60, raising $1.68 billion in gross proceeds, all primary. Honeywell retains the majority economic interest and roughly 48% of combined voting power; Honeywell and Cambridge Quantum Holdings together hold around 82% of the equity post-listing, with founder Ilyas Khan the largest individual holder near 15%. The public float is thin against that overhang, which is precisely the structure that produces a sharp aftermarket once the syndicate stops buying. The private valuation walked from $5 billion in early 2024 to a $10 billion pre-money mark in late 2025 to roughly $15.7 billion at the open. The mark-up was the trade. The public market is now being asked to fund the exit.
The Number That Matters
Not $60. First-quarter 2026 revenue of $5.24 million, down 73% from $19.1 million a year earlier, against a net loss that widened to $136.5 million from $30.5 million. Bookings were $1.3 million versus $1.9 million. Full-year 2025 revenue was $30.9 million against a $192.6 million loss. At a $15.7 billion debut market capitalization, that is on the order of 500 times trailing sales on a revenue line that is contracting, not compounding. Annualize the first quarter and the forward multiple pushes past 700 times against shrinking revenue. There is no margin story because there is barely a revenue story; the equity is priced on a roadmap, and roadmaps do not have a discount rate the market agrees on.
Stock Trajectory
QNT opened at $68 on Thursday, a 13% pop, and ran as high as $71.35 intraday before closing at $60.38, up less than 1%. On Friday the lead underwriters, J.P. Morgan and Morgan Stanley, stepped back from stabilization. The stock broke $60, fell roughly 8% into the $55–$56 area, and traded as low as $54. Anyone who bought the first-day open is down more than 20% inside twenty-four hours. The base case from here is that QNT settles as a high-beta proxy for quantum sentiment, levered to Honeywell’s strategic backing and the optics of the listing. The bull case rests on conversion: the federal quantum package directing about $100 million to Quantinuum, the Mitsubishi Electric framework, enterprise pilots turning into bookings. The bear case is cohort derating, and it is the one the tape is already pricing.
The Position
Friday showed the mechanism directly. IonQ and D-Wave each fell around 15%, Rigetti dropped 16%, and Quantum Computing slid roughly 12%, on a day the broader market lost less than 2%. That is not beta to the macro. That is a sector being marked to a new reference price. The first clean public comparable for full-stack quantum just printed below its offer with revenue going the wrong direction, and every other name in the complex trades off that print. The short thesis was never that the technology is fake; it is that the multiples assume an adoption curve the income statements do not yet show, and the marginal buyer who paid $68 is now the marginal seller. The lockup expiry is the next leg down, releasing the 82% that never had to clear at these prices.
The IPO did not misprice the company. It priced the sector, and the sector just found out what it is worth.